Incorporating Solvent-Dependent Kinetics To Design a Multistage, Continuous, Combined Cooling/Antisolvent Crystallization Process

Combined cooling and antisolvent crystallization enables crystallization of many pharmaceutical products, but its process design typically neglects solvent composition influences on crystallization kinetics. This paper evaluates the influence of solvent-dependent nucleation and growth kinetics on th...

Full description

Bibliographic Details
Main Authors: Schall, Jennifer M. (Author), Capellades Mendez, Gerard (Author), Mandur, Jasdeep S. (Author), Braatz, Richard D. (Author), Myerson, Allan S. (Author)
Other Authors: Massachusetts Institute of Technology. Department of Chemical Engineering (Contributor)
Format: Article
Language:English
Published: American Chemical Society (ACS), 2020-02-28T16:31:07Z.
Subjects:
Online Access:Get fulltext
LEADER 01977 am a22002053u 4500
001 123883
042 |a dc 
100 1 0 |a Schall, Jennifer M.  |e author 
100 1 0 |a Massachusetts Institute of Technology. Department of Chemical Engineering  |e contributor 
700 1 0 |a Capellades Mendez, Gerard  |e author 
700 1 0 |a Mandur, Jasdeep S.  |e author 
700 1 0 |a Braatz, Richard D.  |e author 
700 1 0 |a Myerson, Allan S.  |e author 
245 0 0 |a Incorporating Solvent-Dependent Kinetics To Design a Multistage, Continuous, Combined Cooling/Antisolvent Crystallization Process 
260 |b American Chemical Society (ACS),   |c 2020-02-28T16:31:07Z. 
856 |z Get fulltext  |u https://hdl.handle.net/1721.1/123883 
520 |a Combined cooling and antisolvent crystallization enables crystallization of many pharmaceutical products, but its process design typically neglects solvent composition influences on crystallization kinetics. This paper evaluates the influence of solvent-dependent nucleation and growth kinetics on the design of optimal, multistage mixed-suspension, mixed-product removal (MSMPR) crystallization cascades. The ability to independently select temperature and solvent compositions in each stage of the cascade serves to greatly expand the attainable region for a two-stage cascade, with diminishing returns for additional stages. Failure to include solvent-dependent kinetics can result in simulating incorrect attainable regions, active pharmaceutical ingredient (API) yields, and crystal size distributions. This work also demonstrates that commonly employed crystallization process design heuristics, such as equal antisolvent addition and decreasing temperature in successive stages, can result in suboptimal process design if kinetics are strongly solvent dependent. Keyword: Crystals; Crystallization; Solvents; Nucleation kinetics 
520 |a National Institutes of Health (U.S.) (Grant 1122374) 
655 7 |a Article 
773 |t Organic Process Research and Development